Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, May 24 '25)

Image
By G.M.

 


    AJR Am J Roentgenol

  1. SCHMITT JE, Smerconish S
    Beyond the AJR: Demystifying COVID-19-Related Brain Fog With Perfusion MRI.
    AJR Am J Roentgenol. 2025 May 21. doi: 10.2214/AJR.25.32998.
    PubMed        


    Br J Anaesth

  2. WELLER JM, Long J, Moore M, Henderson K, et al
    Effects of a national team training intervention for operating theatre teams on patient and staff outcomes: a stepped-wedge cluster-randomised trial and mixed-methods study.
    Br J Anaesth. 2025 May 16:S0007-0912(25)00230-2. doi: 10.1016/j.bja.2025.
    PubMed         Abstract available


    Clin Infect Dis

  3. NADIG N, Bhimraj A, Cawcutt K, Chiotos K, et al
    2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab.
    Clin Infect Dis. 2025 May 22:ciaf235. doi: 10.1093.
    PubMed         Abstract available


    Int J Infect Dis

  4. HUANG Q, Kang L, Wei X, Gong C, et al
    Epidemiology and genetic diversity of common human coronaviruses in Beijing, 2015-2023: A prospective multicenter study.
    Int J Infect Dis. 2025 May 14:107926. doi: 10.1016/j.ijid.2025.107926.
    PubMed         Abstract available


    Intensive Care Med

  5. CARLET J, Payen D, Singer M
    A critical assessment of corticosteroid trials for hospitalised patients with SARS-CoV-2 disease.
    Intensive Care Med. 2025 May 23. doi: 10.1007/s00134-025-07878.
    PubMed        


    J Infect

  6. BREUER J, Drysdale M, Walker J, Han J, et al
    Monitoring the Emergence of Resistance With Sotrovimab in Immunocompromised Patients With COVID-19: LUNAR Study.
    J Infect. 2025 May 19:106510. doi: 10.1016/j.jinf.2025.106510.
    PubMed         Abstract available

  7. QI K, Chen J, Ma X, Li D, et al
    Novel Coronaviruses Identified in Livestock: The Urgent Need to Enhance Coronavirus Surveillance to Mitigate Zoonotic Risks.
    J Infect. 2025 May 16:106512. doi: 10.1016/j.jinf.2025.106512.
    PubMed        


    J Med Virol

  8. JANOFF EN, Shih MC, Donskey C, Belitskaya-Levy I, et al
    Impact of High-Titer Convalescent Plasma on Clinical and Virologic Outcomes Among Veterans Hospitalized With SARS-CoV-2 Infection: VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1).
    J Med Virol. 2025;97:e70349.
    PubMed         Abstract available

  9. KANG J, Park J, Son Y, Kim HJ, et al
    Postacute Sequelae of COVID-19 Across 12 Major Health Domains and 141 Diseases in Individuals With Mental Illness Among COVID-19 Survivors: A Population-Based Cohort Study in South Korea.
    J Med Virol. 2025;97:e70406.
    PubMed         Abstract available

  10. CHEN Q, Tan K
    Neurovascular Barrier Protection in COVID-19: Emerging Therapeutic Targets From SARS-CoV-2 Pathogenesis.
    J Med Virol. 2025;97:e70413.
    PubMed        


    J Virol

  11. QIAN Q, Zhao S-s, Yang L, Xing G, et al
    Palmitoylation enhances the stability of porcine epidemic diarrhea virus spike protein by antagonizing its degradation via chaperone-mediated autophagy to facilitate viral proliferation.
    J Virol. 2025 May 22:e0034725. doi: 10.1128/jvi.00347.
    PubMed         Abstract available

  12. WANG Y, Cheng Y, Wang S, Liu D, et al
    Unraveling the cross-talk between a highly virulent PEDV strain and the host via single-cell transcriptomic analysis.
    J Virol. 2025 May 21:e0055525. doi: 10.1128/jvi.00555.
    PubMed         Abstract available

  13. BEAN DJ, Liang YM, Avila F, He X, et al
    Endemic coronavirus infection is associated with SARS-CoV-2 Fc receptor-binding antibodies.
    J Virol. 2025 May 19:e0055025. doi: 10.1128/jvi.00550.
    PubMed         Abstract available


    Lancet Infect Dis


  14. Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet Infect Dis. 2025 May 15:S1473-3099(25)00093.
    PubMed         Abstract available

  15. LUI GCY, Hui DSC
    Revisiting oral antivirals for COVID-19 in the hospital setting.
    Lancet Infect Dis. 2025 May 15:S1473-3099(25)00169.
    PubMed        


    N Engl J Med

  16. PRASAD V, Makary MA
    An Evidence-Based Approach to Covid-19 Vaccination.
    N Engl J Med. 2025 May 20. doi: 10.1056/NEJMsb2506929.
    PubMed        
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »